Nuclear Medicine
NEUROBAC
Name:
Neurobac Radiofarma®
Active Principle:
Bicisate Hydrochloride
Therapeutic Action:
It is indicated for the evaluation of the state of cerebral perfusion by means of scintigraphy applied to patients with disorders in the Central Nervous System.
Nuclear Medicine
NEUROBAC
Name:
Neurobac Radiofarma®
Active Principle:
Bicisate Hydrochloride
Therapeutic Action:
It is indicated for the evaluation of the state of cerebral perfusion by means of scintigraphy applied to patients with disorders in the Central Nervous System.
RELATED PRODUCTS
-
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness... -
131I MIBG BACON (R&D)
131I MIBG BACON (R&D)It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas...

